Bausch Health Announces $63 Million Acquisition of DURECT Corporation to Enhance Liver Disease Solutions
August 9, 2025 - 11:23
Bausch Health Companies Inc. has made a significant move in the healthcare sector by announcing a definitive agreement to acquire DURECT Corporation. This strategic acquisition, valued at approximately $63 million upfront, aims to bolster Bausch Health's portfolio in the treatment of liver diseases. The deal also includes potential sales milestone payments that could reach an additional $350 million, highlighting the company’s confidence in DURECT's innovative therapies.
The acquisition is expected to enhance Bausch Health's capabilities in addressing unmet medical needs within the liver disease treatment landscape. DURECT is known for its advanced drug delivery technologies and therapeutic solutions, which align with Bausch Health's mission to improve patient outcomes.
This acquisition comes at a pivotal time as Bausch Health continues to focus on expanding its product offerings and strengthening its position in the healthcare market. The company believes that integrating DURECT's expertise will accelerate the development of new treatments, ultimately benefiting patients suffering from liver-related conditions.
MORE NEWS
February 21, 2026 - 09:17
I spent 22 years unable to burp. Here’s what happened when I finally could.For decades, a silent and often misunderstood condition governed daily life. Known informally as `no-burp syndrome,` or retrograde cricopharyngeus dysfunction (R-CPD), it leaves sufferers...
February 20, 2026 - 21:10
USF Health Morsani College of Medicine claims two national Top 10 rankings in NIH fundingThe University of South Florida Health Morsani College of Medicine has demonstrated significant research strength, earning two coveted spots in the national Top 10 for National Institutes of Health...
February 20, 2026 - 08:41
Cambridge mental health charity says £205K grant is 'pivotal'A Cambridge-based mental health charity has described a substantial new grant as `pivotal` to its future, enabling a significant expansion of its community services. The organization, Sew Positive,...
February 19, 2026 - 19:15
Svetlana Lipyanskaya, MPA, FACHE to be Appointed CEO of Maimonides Health, Pending Final Approval of Partnership with NYC Health + Hospitals - NYC Health + HospitalsNew York, NY — Svetlana Lipyanskaya, MPA, FACHE, is set to become the new Chief Executive Officer of Maimonides Health, pending final approval of a new partnership between the Brooklyn-based...